Repligen Corp (RGEN)

NASDAQ · Life Sciences Tools & Services

166.18
-2.86 (-1.69%)
Updated Aug 18, 6:52 PM ET
AI Rating
Buy
Overall Score
68
Trend
75
Momentum
77
Risk
46

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 20, 2026 120 sessions Aug 14, 2026

AI Analysis

Repligen Corp is trading at $166.18, down 1.69% on the session. The 50 day average sits at $141.42 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 71, which reads as overbought, and MACD is bullish crossover. Volume is below average.

The nearest support is around $135.08 with resistance near $168.37, so that band frames the current range. Average daily movement is roughly $6.81, or about 4.1% of the share price, which is what any stop placement has to allow for. The overall health score of 68 out of 100 combines a trend score of 75, momentum of 77 and a risk score of 46.

Technical indicators

RSI (14)
71.0
overbought
MACD
7.702
bullish crossover
SMA 20
150.79
SMA 50
141.42
SMA 200
--
unknown
ATR (14)
6.81
avg daily range
Support
135.08
Resistance
168.37
Volume vs 20d
0.47x
below average
Volatility
54.0%
annualised
1 month
+13.39%
3 months
+46.86%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.